Alteration of G1/S Cell Cycle Regulatory Proteins in Carcinogenesis of Cutaneous Squamous Cell Carcinomas;Korean Source G1/S Korean Source

Korean Journal of Pathology

Volumn 43, Issue 6, 2009, Pages 542-549

  Im, Soyoung ^a   Yoo, Changyoung ^a   Jung, Ji Han ^a   Choi, Hyun Joo ^a   Yoo, Jinyoung ^a   Kang, Seok Jin ^a   Lee, Kyo Young ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Carcinoma; Cell cycle; Skin; Squamous cell

Indexed keywords

EID: 77951183823     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2009.43.6.542     Document Type: Article

References (28)

1. Zheng Z, Kye Y, Zhang X, Kim A, Kim I. Expression of p63, bcl-2, bcl-6 and p16 in basal cell carcinoma and squamous cell carcinoma of the skin. Korean J Pathol 2005; 39: 91-8.
2. Nilsson K, Svensson S, Landberg G. Retinoblastoma protein function and p16INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16INK4a expression and infiltrative behavior. Mod Pathol 2003; 17: 1464-74.
3. Salama ME, Mahmood MN, Qureshi HS, Ma C, Zarbo RJ, Ormsby AH. p16INKa expression in actinic keratosis and Bowen's disease. Br J Dermatol 2003; 149: 1006-12.
4. Burnworth B, Arendt S, Muffler S, et al. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1. Eur J Cell Biol 2007; 86: 763-80.
5. Hur HK, Roh MS, Jeong JS, Rha SH, Huh GY, Hong SH. Expression of pRb, p16, cyclin D1 and cyclin E in infiltrating duct carcinoma of the breast. Korean J Pathol 2001; 35: 416-23.
6. Han SH, Lee JH, Kim SH, An J, Lee ES, Kim YS. Expression of p16, Rb and FHIT proteins in urothelial carcinoma of the urinary bladder. Korean J Pathol 2008; 10: 294-8.
7. Kim JY, Kim HW, Choi KU, et al. Alteration of G1/S cell cycle regulatory proteins in ovarian epithelial tumors. Korean J Pathol 2006; 40: 274-81.
8. Lee JS, Shin JG, Ko GH, Lee JH, Kim HW. Studies on the expression of the p16 (INK4A), p53, and Ki-67 labeling index in inflammatory and neoplastic diseases of the uterine cervix. Korean J Pathol 2004; 38: 238-43.
9. Mortier L, Marchetti P, Delaporte E, et al. Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16 (INK4a) tumor suppressor. Cancer Lett 2002; 176: 205-14.
10. Brown VL, Harwood CA, Crook T, Cronin JG, Kelsell DP, Proby CM. p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. J Invest Dermatol 2004; 122: 1284-92.
11. Hodges A, Smoller BR. Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin. Mod Pathol 2002; 15: 1121-5.
12. Conscience I, Jovenin N, Coissard C, et al. P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas. Eur J Dermatol 2006; 16: 518-22.
13. Ruiz S, Santos M, Lara MF, Segrelles C, Ballestin C, Paramio JM. Unexpected roles for pRb in mouse skin carcinogenesis. Cancer Res 2005; 65: 9678-86.
14. Robles AI, Conti CJ. Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis 1995; 16: 781-6.
15. Bianchi AB, Fischer SM, Robles AI, Rinchik EM, Conti CJ. Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene 1993; 8: 1127-33.
16. Edwards MJ, Thomas RC, Wong YL. Retinoblastoma gene expression in human non-melanoma skin cancer. J Cutan Pathol 2003; 30: 479-85.
17. Liang SB, Furihata M, Takeuchi T, et al. Overexpression of cyclin D1 in nonmelanocytic skin cancer. Virchows Arch 2000; 436: 370-6.
18. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990; 17: 489-503.
19. Kanitakis J, Narvaez D, Euvrard S, Faure M, Claudy A. Proliferation markers Ki67 and PCNA in cutaneous squamous cell carcinomas: lack of prognostic value. Br J Dermatol 1997; 136: 643-4.
20. Scurry J, Beshay V, Cohen C, Allen D. Ki67 expression in lichen sclerosus of vulva in patients with and without associated squamous cell carcinoma. Histopathology 1998; 32: 399-404.
21. Shimizu T, Murakami T, Oga A, Furumoto H, Nakano J, Muto M. Prognostic significance of expression of p53 protein and Ki-67 antigen in well-differentiated squamous cell carcinoma of the skin. J Dermatol 1999; 26: 837-40.
22. Baum HP, Meurer I, Unteregger G. Expression of proliferation-associated proteins (proliferating cell nuclear antigen and Ki-67 antigen) in Bowen's disease. Br J Dermatol 1994; 131: 231-6.
23. Chen S, Takahara M, Kido M, et al. Increased expression of an epidermal stem cell marker, cytokeratin 19, in cutaneous squamous cell carcinoma. Br J Dermatol 2008; 159: 952-5.
24. Kim L, Hann SK, Lee KG. Histological and immunohistochemical characteristics of keratoacanthoma and well differentiated squamous cell carcinoma. Korean J Pathol 2000; 34: 145-53.
25. Clausen OP, Aass HC, Beigi M, et al. Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization. J Invest Dermatol 2006; 126: 2308-15.
26. Beham A, Regauer S, Soyer HP, Beham-Schmid C. Keratoacanthoma: a clinically distinct variant of well differentiated squamous cell carcinoma. Adv Anat Pathol 1998; 5: 269-80.
27. Connolly M, Narayan S, Oxley J, de Berker DA. Immunohistochemical staining for the differentiation of subungual keratoacanthoma from subungual squamous cell carcinoma. Clin Exp Dermatol 2008; 33: 625-8.
28. Kaabipour E, Haupt HM, Stern JB, Kanetsky PA, Podolski VF, Martin AM. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study. Arch Pathol Lab Med 2006; 130: 69-73.